Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1988 Feb;100(1):145–151. doi: 10.1017/s0950268800065638

Hepatitis B markers in Lancashire police officers.

P Morgan-Capner 1, P Hudson 1, A Armstrong 1
PMCID: PMC2249199  PMID: 3338501

Abstract

A total of 284 Lancashire police officers each with a minimum of 5 years experience was tested for evidence of hepatitis B infection. None was hepatitis B surface antigen positive (HBsAg). Three were positive for both antibody to hepatitis B core antigen (anti-HBc) and HBsAg (anti-HBs). Five were positive for anti-HBc alone. Thus the overall prevalence was 2.8% which is within the range reported for blood donors in the UK. There was no association with working in the drug squad or custody office but there was a higher prevalence in those who had worked in the scene-of-crime's squad. However, the numbers were small, and of this group of 28 officers, 2 of the 3 with detectable hepatitis B markers were positive for anti-HBc alone. Therefore for police officers in mixed rural/urban areas of the UK, routine administration of hepatitis B vaccine is not justified although special consideration should be given to those working in selected groups. Further studies are required to ascertain whether there may be an increased risk for police officers working in conurbations.

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbas A. M., Denton M. D., Francis R. A. Prevalence of hepatitis B markers among district general hospital staff. Br Med J (Clin Res Ed) 1985 Apr 20;290(6476):1212–1212. doi: 10.1136/bmj.290.6476.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson C. C., Contreras M., Barbara J. A., Mijovic V. Surrogate testing for non-A, non-B hepatitis. Lancet. 1987 Apr 18;1(8538):912–912. doi: 10.1016/s0140-6736(87)92875-3. [DOI] [PubMed] [Google Scholar]
  3. Archer A. C., Cohen B. J., Mortimer P. P. The value of screening blood donors for antibody to hepatitis B core antigen. J Clin Pathol. 1983 Aug;36(8):924–928. doi: 10.1136/jcp.36.8.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cumming C. G., Peutherer J. F., Smith G. L. The prevalence of hepatitis B serological markers in dental personnel. J Infect. 1986 Mar;12(2):157–159. doi: 10.1016/s0163-4453(86)93658-3. [DOI] [PubMed] [Google Scholar]
  5. Deinhardt F., Zuckerman A. J. Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. J Med Virol. 1985 Nov;17(3):209–217. doi: 10.1002/jmv.1890170302. [DOI] [PubMed] [Google Scholar]
  6. Fagan E. A., Tolley P., Smith H. M., Peters M. P., Coleman J., Elliott P., Williams R., Eddleston A. L. Hepatitis B vaccine: immunogenicity and follow-up including two year booster doses in high-risk health care personnel in a London teaching hospital. J Med Virol. 1987 Jan;21(1):49–56. doi: 10.1002/jmv.1890210107. [DOI] [PubMed] [Google Scholar]
  7. Follett E. A., Barr A., Crawford R. J., Mitchell R. Viral hepatitis markers in blood donors and patients with a history of jaundice. Lancet. 1980 Feb 2;1(8162):246–249. doi: 10.1016/s0140-6736(80)90729-1. [DOI] [PubMed] [Google Scholar]
  8. Hepatitis B vaccination policy. Lancet. 1983 Mar 5;1(8323):533–534. [PubMed] [Google Scholar]
  9. Holt P. A., Goodall B., Lees E. M., Hambling M. H. Prevalence of hepatitis B markers in patients and staff in a hospital for the mentally handicapped. J Hosp Infect. 1986 Jan;7(1):26–33. doi: 10.1016/0195-6701(86)90023-x. [DOI] [PubMed] [Google Scholar]
  10. Non-A, non-B hepatitis surrogate testing of blood donations. Lancet. 1987 Jun 13;1(8546):1366–1367. [PubMed] [Google Scholar]
  11. Peterkin M., Crawford R. J. Hepatitis B vaccine for police forces? Lancet. 1986 Dec 20;2(8521-22):1458–1459. doi: 10.1016/s0140-6736(86)92763-7. [DOI] [PubMed] [Google Scholar]
  12. Polakoff S. Acute viral hepatitis B: laboratory reports 1980-4. Br Med J (Clin Res Ed) 1986 Jul 5;293(6538):37–38. doi: 10.1136/bmj.293.6538.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Seeff L. B., Beebe G. W., Hoofnagle J. H., Norman J. E., Buskell-Bales Z., Waggoner J. G., Kaplowitz N., Koff R. S., Petrini J. L., Jr, Schiff E. R. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med. 1987 Apr 16;316(16):965–970. doi: 10.1056/NEJM198704163161601. [DOI] [PubMed] [Google Scholar]
  14. Smith C. E. A study of the prevalence of markers of hepatitis B infection in hospital staff. J Hosp Infect. 1987 Jan;9(1):39–42. doi: 10.1016/0195-6701(87)90093-4. [DOI] [PubMed] [Google Scholar]
  15. Smith T. Protecting policemen against hepatitis B. Occup Health (Lond) 1986 Jul;38(7):229–230. [PubMed] [Google Scholar]
  16. Tedder R. S., Cameron C. H., Wilson-Croome R., Howell D. R., Colgrove A., Barbara J. A. Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol. 1981;6(4):323–332. doi: 10.1002/jmv.1890060407. [DOI] [PubMed] [Google Scholar]
  17. Vandervelde E. M., Mortimer P. P. New hepatitis B vaccines. Br Med J (Clin Res Ed) 1985 Mar 9;290(6470):787–787. doi: 10.1136/bmj.290.6470.787-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Zuckerman A. J. Novel hepatitis B vaccines. J Infect. 1986 Jul;13 (Suppl A):61–71. doi: 10.1016/s0163-4453(86)92713-1. [DOI] [PubMed] [Google Scholar]
  19. Zuckerman A. J. Who should be immunised against hepatitis B? Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1243–1244. doi: 10.1136/bmj.289.6454.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES